Symbols

GTBP

GT Biopharma·NASDAQ

--(--)

GTBP Profile

Gt Biopharma, Inc.

A clinical stage biopharmaceutical company that develops immuno-therapeutic products

Industry

Pharmaceutical

Established Date

Listing Date

02/11/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

ir.gtbiopharma.com

Security Type

Common stock

Office address

315 Montgomery Street, 10th Floor, San Francisco, California 94104

Business

Introduction

GT Biopharma, Inc., was incorporated in California in 1965. The Company is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products with a proprietary tri-specific killer adapter fusion protein immune cell adapter technology platform. TriKE can be designed to target any number of tumor antigens in hematological malignancies or solid tumors and does not require patient-specific customization.